Literature DB >> 18308193

Narrowing in on cardiovascular disease: the atheroprotective role of peroxisome proliferator-activated receptor gamma.

Jon M Gerry1, Gabriel Pascual.   

Abstract

Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a nuclear receptor that has been suggested to play protective roles in the pathogenesis of diseases that are characterized by chronic inflammation, such as atherosclerosis. The study of nuclear receptors, including PPAR gamma, has led to the discovery of anti-inflammatory processes that are collectively known as transrepression. In this review, we will highlight some of the mechanisms of PPAR gamma-mediated transrepression that have surfaced throughout the past decade. We will also discuss the existing evidence for an atheroprotective role of PPAR gamma as a repressor of inflammatory genes and as a key determinant of distinct monocyte-derived subpopulations that may serve an anti-inflammatory, homeostatic role in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18308193     DOI: 10.1016/j.tcm.2007.12.001

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  7 in total

1.  Inhibiting DNA Methylation by 5-Aza-2'-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation.

Authors:  Qiang Cao; Xianfeng Wang; Lin Jia; Ashis K Mondal; Abdoulaye Diallo; Gregory A Hawkins; Swapan K Das; John S Parks; Liqing Yu; Huidong Shi; Hang Shi; Bingzhong Xue
Journal:  Endocrinology       Date:  2014-09-24       Impact factor: 4.736

Review 2.  Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology.

Authors:  Min K Song; Basil D Roufogalis; Tom H W Huang
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 3.  Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.

Authors:  Salman Azhar
Journal:  Future Cardiol       Date:  2010-09

4.  Is PPARG the key gene in diabetic retinopathy?

Authors:  Valerio Costa; Alfredo Ciccodicola
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

5.  9- and 13-HODE regulate fatty acid binding protein-4 in human macrophages, but does not involve HODE/GPR132 axis in PPAR-γ regulation of FABP4.

Authors:  Venkat Vangaveti; Venkatesh Shashidhar; Fiona Collier; Jason Hodge; Catherine Rush; Usman Malabu; Bernhard Baune; Richard Lee Kennedy
Journal:  Ther Adv Endocrinol Metab       Date:  2018-02-27       Impact factor: 3.565

6.  Exploring the Pharmacological Mechanism of Liuwei Dihuang Decoction for Diabetic Retinopathy: A Systematic Biological Strategy-Based Research.

Authors:  Mengxia Yuan; Qi He; Zhiyong Long; Xiaofei Zhu; Wang Xiang; Yonghe Wu; Shibin Lin
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-02       Impact factor: 2.629

7.  Association between PPAR-γ2 gene polymorphisms and diabetic retinopathy risk: a meta-analysis.

Authors:  Xue-Feng Li; Guang-Bin Jiang; Shi-Yan Cheng; Ya-Feng Song; Cai Deng; Yu-Ming Niu; Jun-Wei Cai
Journal:  Aging (Albany NY)       Date:  2021-02-01       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.